Infectious agent air treatment system, apparatus, and method
AssigneeG.H.L. International, Inc.
InventorsJohn M. Lipscomb, Edgar C. Paffrath
Life of this patent
Estimating the term…
Loading patent…
AssigneeG.H.L. International, Inc.
InventorsJohn M. Lipscomb, Edgar C. Paffrath
Estimating the term…
An air treatment system, e.g., used in a PPE mask, contains media with an infectious agent attenuator that attenuates or inactivates infectious agents in air flowing through passages in a media, the attenuator composed of moisture-activated biocide, e.g., organic acid like citric acid, and a humectant, e.g., gelling humectant like sorbitol, which captures moisture from the air to maintain biocide activation. A surfactant, such as a rhamnolipid surfactant, which attracts and encapsulates infectious agents in the air can be included. The attenuator has a pH≤5, preferably ≤4, more preferably ≤3.5, is kept activated at or below the desired pH by humectant capturing moisture in the breath of a person wearing a mask with the media. A preferred biocide is composed of a solution containing about 88% water and 12% of a mixture that is at least 80% citric acid and no more than 20% sorbitol.
An air treatment system comprised of an air treatment media having at least a plurality of pairs of air flow passages formed therein and an infectious agent attenuator configured to attenuate or inactivate infectious agents in the air flowing through the air flow passages in the air treatment media, the infectious agent attenuator comprised of:
An air treatment system comprised of an air treatment media having at least a plurality of pairs of air flow passages formed therein and extending therethrough, and an infectious agent attenuator configured to attenuate or inactivate infectious agents in air flowing through the air flow passages in the air treatment media, the infectious agent attenuator comprised of:
Dependencies are inferred from the claim text.